Roundhill GLP-Other EquityOZEM · Nasdaq

Roundhill GLP-1 & Weight Loss ETF (OZEM)

Loading NAV history…

Roundhill GLP-1 & Weight Loss ETF

Fund only: no comparison series covers this fund's history.

Five years of daily closes. Risk-free rate 4% a year.

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	-7.3%	+1.9%	-0.6%	-8.9%	+21.1%	—	—	—	+9.9%
Other Equity average	-1.6%	0.8%	11.5%	11.5%	15.4%	15.4%	6.5%	—	8.9%
Difference	-5.7%	+1.0%	-12.1%	-20.3%	+5.7%	—	—	—	+1.0%

Holdings

The 10 largest positions make up 65.0% of the fund.

Largest holdings by weight
Ticker	Holding	Weight
NVO	Novo Nordisk AS ADR	12.05%
LLY	Eli Lilly and Co	12.02%
PFE	Pfizer Inc	7.42%
1093.HK	CSPC Pharmaceutical Group Ltd	6.91%
VKTX	Viking Therapeutics Inc	4.84%
128940.KQ	Hanmi Pharm Co Ltd	4.82%
AMGN	Amgen Inc	4.49%
KLRA	Kailera Therapeutics Inc	4.27%
4519.T	Chugai Pharmaceutical Co Ltd	4.12%
ZEAL.CO	Zealand Pharma AS	4.06%

Weighted averages of what the fund holds.

Share of the equity the fund holds.

Prices and returns as of 11 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other ETFs in the Other Equity category.